Section 1 Introduction
Section 2 General Considerations
2.1 Transmissible Spongiform Encephalopathies in Humans and in Animals
2.2 Diagnosis of Human Transmissible Spongiform Encephalopathies
2.3 Iatrogenic Transmission
2.4 Evaluating Risk in Healthcare Environments |
Section 3 Patient Care
3.1 Care of Patients in the Home and Healthcare Settings
3.2 Dental Procedures
3.3 Diagnostic Procedures
3.4 Surgical Procedures
3.5 Handling of Surgical Instruments
3.6 Anaesthesia
3.7 Pregnancy and Childbirth |
Section 4 Occupational Injury
4.1 Occupational Exposure
4.2 Post-exposure Management |
Section 5 Laboratory Investigations
5.1 Safety in the Healthcare Laboratory
5.2 Clinical Diagnostic Laboratories
5.3 Surgical Pathology
5.4 Transport of Specimens by Air |
Section 6 Decontamination Procedures
6.1 General Considerations
6.2 Decontamination of Instruments
6.3 Decontamination of Work Surfaces
6.4 Decontamination of Wastes and Waste-contaminated Materials
6.5 Personal Protection During Decontamination Procedures
6.6 Decontamination Risk Categories |
| Section 7 Waster Disposal |
Section 8 After Death
8.1 Precautions for Handling of the Deceased Patient
8.2 Post Mortem Examination
8.3 National and International Transport of Bodies
8.4 Undertakers and Embalmers
8.5 Funerals and Cremations
8.6 Exhumations
8.7 Body Donation for Teaching Purposes |
| Annex 1 List of Participants |
| Annex 2 List of Presentations |
| Annex 3 Decontamination Methods for Transmissible Spongiform Encephalopathies |
| Annex 4 Management of Healthy 'At Risk' Individuals |
| Annex 5 Management of Individuals with Confirmed or Suspected Variant Creutzfeldt-Jakob Disease |
